Drug Type Mesenchymal stem cell therapy |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bronchopulmonary Dysplasia | Phase 2 | South Korea | 01 Apr 2013 | |
Obstetric Labor, Premature | Phase 2 | South Korea | 01 Apr 2013 | |
Dementia due to Alzheimer's disease (disorder) | Phase 1 | South Korea | 01 Feb 2011 |
NCT01828957 (Pubmed) Manual | Phase 2 | 66 | qrfeseowri(ponaivmqog) = ptvhqdxwre mquowrwgqy (csazkkjqmm ) View more | Positive | 01 Aug 2021 | ||
Placebo | qrfeseowri(ponaivmqog) = oravmwkrmo mquowrwgqy (csazkkjqmm ) View more | ||||||
NCT01297218 (Pubmed) Manual | Phase 1 | 9 | hUCB-MSCs (low-dose) | smzdalncmw(cnlaqjeiog) = No patient showed serious adverse events including fever during gmxycotonv (titbjvotqq ) View more | Positive | 26 Jul 2015 | |
hUCB-MSCs (high-dose) |